Qian Chaonan

PhD in Oncology

Chief Physician
Professor
Doctoral Supervisor

Guangzhou Taihe Cancer Hospital

Specialty: Otolaryngology (ENT)

Languages: English · Mandarin

Conditions Treated

Nasopharyngeal carcinoma

Expertise

Professor Chaonan Qian is a leading specialist in nasopharyngeal carcinoma, combining clinical care with translational research on tumor metastasis, angiogenesis and drug resistance. His experience supports individualized diagnosis, treatment planning and multidisciplinary management for patients with nasopharyngeal carcinoma, particularly when complex oncologic decisions are required. Postdoctoral training at MD Anderson Cancer Center and Van Andel Research Institute strengthened his international research perspective. As President of Guangzhou Concord Cancer Center and a former Vice President of Sun Yat-sen University Cancer Center, he brings together clinical expertise, cancer research and multidisciplinary leadership.

Experience

Current position

PresidentGuangzhou Taihe Cancer Hospital · Radiation Oncology

Academic role

Professor and Lead Clinician for Nasopharyngeal CarcinomaSun Yat-sen University Cancer Center

Credentials & memberships

Vice-Chair of the CSCO Expert Committee on Vascular-Targeted Therapy
Founding Chair of the CACA Tumor Microenvironment Committee

Education & Training

2003

Postdoctoral trainingThe University of Texas MD Anderson Cancer Center and Van Andel Research InstituteCompleted postdoctoral training at The University of Texas MD Anderson Cancer Center and Van Andel Research Institute between 2000 and 2003.

1999

PhDSun Yat-sen University of Medical SciencesEarned a PhD from Sun Yat-sen University of Medical Sciences in 1999.

Research & Publications

New frontiers in proton therapy: applications in cancers Cancer Communications, 2019.
SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor Cancer Research, 2017.
As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling Carcinogenesis, 2012.
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis Cancer Research, 2011.
The prevalence and prevention of nasopharyngeal carcinoma in China Chinese Journal of Cancer, 2011.
Preparing the “soil”: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells Cancer Research, 2006.

Locations

Guangzhou Concord Cancer Center

No. 9 Ciji Road, Sino-Singapore Guangzhou Knowledge City, Huangpu District, Guangzhou, Guangdong Province, China Get directions